Jacobs has been selected to provide engineering, procurement, construction management, and commissioning/qualification/validation (EPCMCQV) to retrofit AstraZeneca’s West Chester, Ohio manufacturing facility to deliver a potential vaccine to fight the COVID-19 virus.
Jacobs’ work includes upgrading an existing idle Fill Line to support formulation, vial filling, visual inspection and packaging of the COVID-19 vaccine at the earliest date possible in the fall of 2020.
“We’re eager to help AstraZeneca meet the challenge of providing a potential vaccine in record time,” said Jacobs People & Places Solutions, Global Operations, Senior Vice President, Ken Gilmartin. “The world is anxiously waiting for a cure for the novel Coronavirus and we are committed to using our vaccine manufacturing capabilities and doing all we can to make AstraZeneca’s ambition a reality.”